about
Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.Voice profile after type I or II laser chordectomies for T1a glottic carcinoma.Prediction of survival with alternative modeling techniques using pseudo values.Model-assisted predictions on prognosis in HNSCC: do we learn?Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcomeNoncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician.Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.Zenker's diverticulum: Rotterdam experience.Comorbidity as a major risk factor for mortality and complications in head and neck surgery.Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequencyAbsent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.Parathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patients.Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging.Optical image-guided cancer surgery: challenges and limitations.Resection margins in oral cancer surgery: Room for improvement.Investigation of the potential of Raman spectroscopy for oral cancer detection in surgical margins.Detection of oral squamous cell carcinoma and cervical lymph node metastasis using activatable near-infrared fluorescence agents.Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.Incidence and prediction of major cardiovascular complications in head and neck surgery.Update and external validation of a head and neck cancer prognostic model.Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression.Experience of palliative care for patients with head and neck cancer through the eyes of next of kin: impact of an Expert Center.Psychosocial consequences for partners of patients after total laryngectomy and for the relationship between patients and partners.Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells.Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas.Survival of patients with palliative head and neck cancer.Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.Quality of life and illness perceptions in patients with recently diagnosed head and neck cancer.Raman spectroscopic analysis of the molecular composition of oral cavity squamous cell carcinoma and healthy tongue tissueDiscrimination between oral cancer and healthy tissue based on water content determined by Raman spectroscopyPrognosis: A variable parameter. Dynamic prognostic modeling in head and neck squamous cell carcinomaInfluence of previous tumours on survival in early (Tis-T1) glottic carcinomaOutcome of radiotherapy in T1 glottic carcinoma: a population-based study
P50
Q33431325-69FC15D6-1316-498E-BF1E-77D3F3AAF6C1Q33442928-A6F8D053-9421-44F8-AB0F-6798ACD0BDCEQ33783969-D759F811-8180-410A-A915-55B1CCEC4EBFQ34013466-AB0B3725-48EE-4247-A80E-C944C39F07FAQ34021261-CA101D28-3DE1-4328-8864-87E1DBFC0A6DQ35688559-F4AF7AC6-0E20-4708-8A6B-8A2BD4DB6A53Q35769567-5A45EEC5-93DC-4BB9-8F9C-06019E576AB5Q35844051-83B1F304-F640-4B12-BEC3-BC10B5E73725Q36012024-E2D9E05B-1EC5-478D-8B73-40484AEF5725Q36280977-2CE396E7-DF1E-4AB4-BC14-E3DEF2824E98Q36521194-F17A7444-E3ED-4462-AFD5-084B88E83882Q36783066-4615A8FF-A317-42C4-BCAC-2646D782D4B6Q37022410-3F423D4A-021B-4A08-A0FC-DF3A25C86B8DQ37268509-FBD9230C-8A5E-4771-94D9-DBBE49FE5916Q37833963-7659D2AA-CEA4-46A6-9478-A30F1D1DC462Q38106929-35AFD6B6-82C5-4201-A905-CFB4372FC4D9Q38433753-1A0E2AE6-DB71-4923-A721-A1B6B843457CQ38978246-95D6010B-BCA8-4F80-A724-0AEFDA14DF88Q39521110-403AAA5D-B0BD-4A2E-ACC7-0C63B450106FQ40046731-ABC38614-535C-45DA-AB80-EDD79A6D75D8Q42250490-3176D448-F50D-43CD-B982-020AC86B0A89Q42254654-38D33316-A31C-4311-A2C3-D8D539E187C2Q42263135-9E812EA4-06C0-4E41-84F4-9D2A8ADEB2C5Q43166412-8172EF61-6C3F-4A7A-BAAA-502B9F5BA70AQ43478377-33312316-BE7E-48D1-BD48-4EF333DA9EE8Q43564259-F13EDAAC-2BD7-4194-A770-9C18EF532FD4Q43776310-F0D58557-890C-4FEF-87F6-F30E6012A392Q44129302-0AA8F3E3-F5BD-4706-B819-D8E9D00A417DQ46601024-1261AE4A-D4D9-4F65-8A41-54765FC0E195Q47325165-6CF79DEA-C0C4-44C4-9177-6DA2B9AF15A0Q50546203-EDBF7326-2F14-4A6E-8EC3-57E9EC93D1EAQ50758364-2E8D26A2-0F54-4987-8859-6DB558FDA03FQ53061084-AC25C052-8340-45DC-805A-0758D71D24F7Q53122617-4A0D129D-C31D-4FBB-B600-4477A3CAAE0DQ53284288-E34E45EB-B717-43FB-BE9A-77C66041AA7EQ57135045-4B9222BD-3A3C-4F58-8B3E-6986D1D25CB5Q57160862-983BB24F-313C-4CDC-93CA-E010FEEE1700Q57259800-241EDA3B-6E4C-4629-A5D8-3DE9706089FAQ57788587-7E0171C2-28C8-496E-AA79-D5655FD5286BQ57788619-A548CD33-1281-42A5-A44C-63F3990B7094
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert Baatenburg De Jong
@ast
Robert Baatenburg De Jong
@en
Robert Baatenburg De Jong
@es
Robert Baatenburg De Jong
@nl
Robert Baatenburg De Jong
@sl
type
label
Robert Baatenburg De Jong
@ast
Robert Baatenburg De Jong
@en
Robert Baatenburg De Jong
@es
Robert Baatenburg De Jong
@nl
Robert Baatenburg De Jong
@sl
altLabel
Robert Baatenburg de Jong
@en
prefLabel
Robert Baatenburg De Jong
@ast
Robert Baatenburg De Jong
@en
Robert Baatenburg De Jong
@es
Robert Baatenburg De Jong
@nl
Robert Baatenburg De Jong
@sl
P106
P21
P31
P496
0000-0001-7236-264X